ESC 2026 RecapExplore the Hot Line trials, expert perspectives, and key takeawaysExplore the recap→Papers from every journal, all in one place. Create custom feeds.
Offers structured fit-for-duty guidance for tactical athletes; extends prior competitive sports cardiology frameworks to military, law enforcement, and firefighter populations.

May support ticagrelor-aspirin for functional benefit in multiple-infarct stroke after thrombolysis; extends TAPIS but remains hypothesis-generating pending confirmation.

May support PRS for HCM risk stratification; extends prior GWAS to SCD prediction in sarcomere-negative cases.
Automated scoring may match manual HFpEF diagnostic accuracy; extends deep learning echo validation but leaves prospective adoption open.

PCI confers no mortality benefit in TAVI candidates with CAD; challenges routine revascularization and supports selective deferral.

Supports fluoroscopy-only pulsed-field ablation for durable PVI; confirms no added benefit from electroanatomic mapping in this RCT.

Impaired early post-implant GLS may flag higher PICM risk; leaves open whether strain-guided interventions improve outcomes.

May enhance cardiometabolic risk stratification beyond traditional factors; extends evidence from 18 cohorts but requires prospective validation.

NiCARDIA may delineate functional trajectories in Japanese CVD patients; hypothesis-generating until linked analyses complete.

These standards should raise preclinical cardio-oncology research quality; extends consensus by defining essential versus desirable benchmarks for models.
